Venn Brown

Institutional-quality, issuer sponsored reseach

  • Venn Brown is a specialist small and mid-cap equity research house. Our top-rated analysts undertake comprehensive research on some of Australia’s most promising and underappreciated small and mid-cap companies. Our goal is to help some of Australia's best companies grow their investor base, while introducing investors to these undiscovered gems.
  • Visit provider site at https://www.vennbrown.com/
Login

Latest Content

Racura Oncology (ASX:RAC): One drug, three shots

Racura Oncology Ltd

  • 03 Aug 26
  • -
Artrya (ASX:AYA): Downgrade valuation, but market overraction represents buying opportunity

Artrya Limited (AYA:ASX)HeartFlow, Inc. (HTFL:NAS)

  • 30 Jul 26
  • -
Artrya (ASX:AYA): Disappointing 4Q26 cash flow

Artrya Limited

  • 29 Jul 26
  • -
Artrya (ASX:AYA): On track to join the ASX300 in September

Artrya Limited

  • 06 Jul 26
  • -
Artray (ASX:AYA): Positive customer feedback with scan volumes growing 200%/mth; SAPPHIRE study to kick off in July; Appoints former Pro Medicus CFO as new CFO

Artrya Limited (AYA:ASX)HeartFlow, Inc. (HTFL:NAS)

  • 18 May 26
  • -
Artrya (ASX:AYA): 3Q26 cash flow, timing delays cash, $77m on balance sheet, SCF submission expected by Jul-26

Artrya Limited

  • 30 Apr 26
  • -
 

Venn Brown Research and Daily Commentaries

Research Tree offers Venn Brown research, providing ongoing coverage of 3 shares. We offer 7 reports from Venn Brown on Research Tree.

  • Research reports provided by Venn Brown

  • Companies covered by Venn Brown

  • Sectors covered by Venn Brown